As part of a unique summer internship, Thompson is informing researcher training and data access procedures for the Ontario Hereditary Cancer Research Network (OHCRN). With a lifelong interest in health sciences and a passion for promoting equity for In...

TMIST, co-led by Canadian researchers, is working to determine whether a newer form of breast imaging can better detect aggressive breast cancers. The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) is one of the largest breast cancer screeni...

DCAF1 is a donut shaped WD40 repeat protein and a substrate receptor of two distinct E3 ligases. In HIV-1 infection, the viral protein Vpr binds to the top surface of DCAF1, changes its substrate specificity to degrade human proteins involved in antivir...

CATALYST will speed progress toward better detection, diagnosis and treatment for patients. May 13, 2026, ONTARIO — Four new research studies funded by the Ontario Institute for Cancer Research (OICR)...

YouTube video by Ontario Institute for Cancer Research - OICR

OICR is leading a province-wide initiative to advance molecular residual disease (MRD) research and bring tests to patients. “Did you get it all?” It's often the first question a patient asks after cancer treatment, and one of the toughest questions for...

OICR funding is leveraging Ontario’s drug discovery expertise to answer the call for improved treatment options April 9, 2026 (Toronto) – Better cancer care depends on better treatment options. That’s...

Dr. Glenn Bauman recently completed his time acting as an advisor within OICR’s Clinical Translation program. In this Q and A he chats about his longtime involvement with OICR, the Institute’s critica...

Research from the Ontario Institute for Cancer Research associated a chemotherapy-related cellular process with genetic mutations and used it to identify novel cancer driver alterations. New research ...

Topoisomerases resolve topological DNA stress via double-strand breaks and are established targets of cancer chemotherapies. Here, the authors link genomic binding of TOP2B with localized mutational p...

OICR sponsored fourth-year undergrad Chelsea Leduc to study in a molecular biology lab through the 2025 BioCanRx Indigenous Summer Student Internship. It was during the summer after Chelsea Leduc’s fi...

Dr. Raymond Kim co-led the development of 18 recommendations to improve outcomes for Lynch Syndrome, a condition that increases the risk of multiple cancers. Experts in cancer, genetics and medicine c...

Science is more than just data and analysis. There's a story behind every scan, every slide and every line of code. It starts with a person. In cancer research, it's the story of a patient with a family, friends and hopes for the future, and the story o...

Science is more than just data and analysis. There’s a story behind every scan, every slide and every line of code.  In cancer research, it’s the story of a patient with a family, friends and hopes fo...

Canadian Indigenous Nurses Association and the Ontario Institute for Cancer Research partner to increase Indigenous inclusion in cancer research to improve cancer outcomes June 9, 2025, TORONTO – The ...

A collaboration between OICR, University Health Network and the Marathon of Hope Cancer Centres Network can help inform the next evolution of cancer care in this country. By studying the care trajecto...